In helping prepare a nursing care plan for a 90-pound, 82-year-old woman with iron-deficiency anemia with a hemoglobin of 8.2, the nurse agrees that the most appropriate nursing diagnosis would be:

A. Skin color: While changes in skin color can occur in hemochromatosis due to excess iron deposition, it is not the most important parameter to monitor for the effectiveness of deferoxamine.
B. Liver function: Liver function tests can be abnormal in hemochromatosis due to iron overload, but monitoring liver function alone may not adequately assess the effectiveness of deferoxamine in reducing iron levels.
C. Hematocrit: Hematocrit measures the proportion of blood that is made up of red blood cells and may be elevated in hemochromatosis, but it is not the primary parameter to monitor the effectiveness of deferoxamine.
D. Serum iron level: Serum iron level is the most direct indicator of iron overload and the effectiveness of deferoxamine in chelating and removing excess iron from the body.

A. Raloxifene hydrochloride is a selective estrogen receptor modulator (SERM) that is used for the prevention and treatment of osteoporosis in postmenopausal women. It helps to prevent bone loss and reduce the risk of fractures by acting similarly to estrogen in some tissues and antagonizing estrogen in others.
B. Levothyroxine is a thyroid hormone replacement medication used to treat hypothyroidism, not osteoporosis.
C. Escitalopram oxalate is an antidepressant medication used to treat depression and anxiety disorders, not osteoporosis.
D. Calcitonin is a hormone involved in calcium regulation, and calcitonin nasal spray is sometimes used in the treatment of osteoporosis, but it is not typically the first-line treatment option.